Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating cervical hypertrophy

A technology of cervical hypertrophy and medicine, applied in the field of medicine, can solve problems such as cervical canal stenosis, adhesion, liver damage, etc., and achieve the effect of significant cervical hypertrophy and remarkable effect

Inactive Publication Date: 2015-10-21
WUXI SANGNIAN TECH
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The former is easy to cause side effects such as drug resistance and liver damage, while the latter requires special equipment and professional operators, and may cause cervical canal stenosis and adhesions after treatment.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament for treating cervical hypertrophy
  • Medicament for treating cervical hypertrophy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0015] Example Preparation of the medicament of the present invention

[0016] Taking suppositories as an example, the preparation process steps of the medicament of the present invention are as follows:

[0017] (1) Weigh 80 grams of human blood seven, 150 grams of Selaginella thin-leaf, 150 grams of red peony, 80 grams of licorice, 150 grams of Kudiding, 60 grams of Achyranthes bidentata, 50 grams of Morinda officinalis, 150 grams of white bark , 80 grams of cicada slough, 150 grams of sand fennel, 50 grams of Luoshuanghong, 120 grams of pine wormwood, 60 grams of rain leek, 120 grams of dense flowers, 100 grams of calendula root, 100 grams of tamarisk, 50 grams of blue fruit, 100 grams of lilac , 150 grams of shrimp flower, 80 grams of sala seed, 120 grams of white fungus;

[0018] (2) Grind Pleurotus chinensis, Sichuan Achyranthes bidentata, and Tamarix into fine powder, pass through a 120-mesh sieve, and set aside;

[0019] (3) Human blood seven, red peony root, licoric...

experiment example

[0021] Experimental example The effect of the medicament of the present invention in treating cervical hypertrophy

[0022] 1. General information 80 patients with cervical hypertrophy were selected and divided into an observation group of 50 cases and a control group of 30 cases. The patients in the observation group were between 21 and 48 years old, with an average age of 35.6 years; the patients in the control group were between 20 and 45 years old, with an average age of 32.5 years. All patients were excluded from cervical cancer, acute reproductive system inflammation and systemic diseases. Before treatment, according to Table 1, the symptom scores of the two groups of patients were scored. The average score of the observation group was 6.24±1.58, and the average score of the control group was 5.92±1.87. By t test analysis, there was no significant difference in age and symptom scores between the two groups (p>0.05).

[0023] Table 1 Symptom Rating Form

[0024]

[...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an agent for treating cervical hypertrophy. The agent is prepared from the following materials in parts by weight: 1-10 parts of stylophorum lasiocarpum, 10-20 parts of selaginella delicatula, 10-20 parts of root of common peony, 1-10 parts of liquorice root, 10-20 parts of bunge corydalis herb, 1-10 parts of medicinal cyathula root, 1-10 parts of morinda officinalis, 10-20 parts of tengyuch euonymus bark, 1-10 parts of periostracum cicada, 10-20 parts of etlingera yunnanense, 1-10 parts of ilex serrata, 10-20 parts of phtheirospermum japonicum, 1-10 parts of korsakow's monochoria, 10-20 parts of buddleia officinalis maxim, 1-10 parts of calendula root, 5-15 parts of tamarix chinensis, 1-10 parts of fruit of indigo plant, 5-15 parts of syringa oblata lindl, 10-20 parts of woodfordia fruticosa, 1-10 parts of Chinese buckeye seeds and 10-20 parts of pleurotus albellus. The agent disclosed by the invention has a significant effect on treatment of cervical hypertrophy, and is worthy of clinical application and popularization.

Description

[0001] The present invention is a divisional application of a patent with the application number 201510063401.6, the application date is February 6, 2015, and the invention name is "A Medicament for Treating Cervical Hypertrophy". technical field [0002] The invention relates to the field of medicine, in particular to a medicament for treating cervical hypertrophy. Background technique [0003] Cervical hypertrophy is caused by mycoplasma, chlamydia, bacteria, viruses and other pathogens infecting the cervical mucosa, causing cervical congestion, edema, and hyperplasia of cervical glands and stroma. Intrauterine bleeding and ovarian dysfunction can also cause cervical hypertrophy. The main clinical symptoms include increased vaginal discharge, lumbosacral pain, lower abdominal swelling, and bleeding during sexual intercourse. Delayed treatment or improper treatment may lead to endometritis, tubal adhesions, oophoritis, etc. In severe cases, it may lead to infertility or ce...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/88A61P15/00A61K35/64
Inventor 李志刚
Owner WUXI SANGNIAN TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com